Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism:: A randomized, placebo-controlled study

被引:87
作者
Smit, JWA
Eustatia-Rutten, CFA
Corssmit, EPM
Pereira, AM
Frölich, M
Bleeker, GB
Holman, ER
van der Wall, EE
Romijn, JA
Bax, JJ
机构
[1] Leiden Univ, Ctr Med, Dept Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Ctr Med, Dept Clin Chem, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Ctr Med, Dept Cardiol, NL-2300 RC Leiden, Netherlands
关键词
D O I
10.1210/jc.2005-0620
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Subclinical hyperthyroidism has been reported to affect systolic and diastolic cardiac function. However, the reversibility of these effects is not well established. Objective: Our objective was to investigate the presence and reversibility of cardiac abnormalities in patients with long- term exogenous subclinical hyperthyroidism. Design: We conducted a prospective, single- blinded, placebo- controlled randomized trial of 6 months duration with two parallel groups. Setting: The study occurred at the Leiden University Medical Center, a tertiary referral center for thyroid carcinoma. Patients: As a model for subclinical hyperthyroidism, 25 patients with a history of differentiated thyroid carcinoma with more than 10 yr of TSH suppressive therapy with L- T4 were studied. Interventions: L- T4 dose was replaced by study medication containing L- T4 or placebo. Medication was titrated in a single- blinded fashion to establish continuation of TSH suppression ( low- TSH group) or euthyroidism ( euthyroid group). Measurements: We assessed serum levels of free T4 and TSH and used echo Doppler cardiography including tissue Doppler to establish left ventricular ( LV) dimensions and function as well as diastolic function. Baseline echocardiography data were compared with 24 controls. Results: There were no differences in baseline cardiac parameters and TSH levels between the two groups. Although mean LV mass index was increased as compared with 24 controls, only four patients had LVhypertrophy at baseline. This was not improved by restoration of euthyroidism. At baseline, diastolic function was impaired in all patients as indicated by abnormal values for the peak flow of the early filling phase ( E, 55.3 +/- 9.5 mm/ sec), the ratio of E and the peak flow of the atrial filling phase ( E/ A ratio, 0.87 +/- 0.13), the early diastolic velocity obtained by tissue Doppler ( E', 5.7 +/- 1.3 cm/ sec), and the peak atrial filling velocity obtained by tissue Doppler ( A', 6.8 +/- 1.4 cm/ sec), prolonged E deceleration time ( 234 +/- 34 msec), and isovolumetric relaxation time ( 121 +/- 15 msec). After 6 months, significant improvements were observed in the euthyroid group in the E/ A ratio ( + 41%; P < 0.001), E deceleration time ( - 18%; P = 0.006), isovolumetric relaxation time ( - 25%; P < 0.001), E' (+ 31%; P < 0.001), and the E'/ A' ratio (+40%; P < 0.001). Conclusions: We conclude that prolonged subclinical hyperthyroidism is accompanied by diastolic dysfunction that is at least partly reversible after restoration of euthyroidism. Because isolated diastolic dysfunction may be associated with increased mortality, this finding is of clinical significance.
引用
收藏
页码:6041 / 6047
页数:7
相关论文
共 33 条
[1]   Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine [J].
Biondi, B ;
Fazio, S ;
Cuocolo, A ;
Sabatini, D ;
Nicolai, E ;
Lombardi, G ;
Salvatore, M ;
Sacca, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) :4224-4228
[2]   Effects of subclinical thyroid dysfunction on the heart [J].
Biondi, B ;
Palmieri, EA ;
Lombardi, G ;
Fazio, S .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (11) :904-914
[3]   CONTROL OF ADRENERGIC OVERACTIVITY BY BETA-BLOCKADE IMPROVES THE QUALITY-OF-LIFE IN PATIENTS RECEIVING LONG-TERM SUPPRESSIVE THERAPY WITH LEVOTHYROXINE [J].
BIONDI, B ;
FAZIO, S ;
CARELLA, C ;
SABATINI, D ;
AMATO, G ;
CITTADINI, A ;
BELLASTELLA, A ;
LOMBARDI, G ;
SACCA, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1028-1033
[4]   Subclinical hypothyroidism and cardiac function [J].
Biondi, B ;
Palmieri, EA ;
Lombardi, G ;
Fazio, S .
THYROID, 2002, 12 (06) :505-510
[5]   CARDIAC EFFECTS OF LONG-TERM THYROTROPIN-SUPPRESSIVE THERAPY WITH LEVOTHYROXINE [J].
BIONDI, B ;
FAZIO, S ;
CARELLA, C ;
AMATO, G ;
CITTADINI, A ;
LUPOLI, G ;
SACCA, L ;
BELLASTELLA, A ;
LOMBARDI, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) :334-338
[6]   Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients [J].
Biondi, B ;
Palmieri, EA ;
Fazio, S ;
Cosco, C ;
Nocera, M ;
Saccà, L ;
Filetti, S ;
Lombardi, G ;
Perticone, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) :4701-4705
[7]   LEFT-VENTRICULAR DIASTOLIC DYSFUNCTION AS A CAUSE OF CONGESTIVE-HEART-FAILURE - MECHANISMS AND MANAGEMENT [J].
BONOW, RO ;
UDELSON, JE .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (06) :502-510
[8]   Usefulness of tissue Doppler imaging for estimation of filling pressures in patients with primary or secondary pure mitral regurgitation [J].
Bruch, C ;
Stypmann, J ;
Gradaus, R ;
Breithardt, G ;
Wichter, T .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (03) :324-328
[9]   Doppler tissue analysis of mitral annular velocities: Evidence for systolic abnormalities in patients with diastolic heart failure [J].
Bruch, C ;
Gradaus, R ;
Gunia, S ;
Breithardt, G ;
Wichter, T .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2003, 16 (10) :1031-1036
[10]   Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis [J].
Ching, GW ;
Franklyn, JA ;
Stallard, TJ ;
Daykin, J ;
Sheppard, MC ;
Gammage, MD .
HEART, 1996, 75 (04) :363-368